Danimer Scientific, Inc. (NYSE:DNMR) Q4 2023 Earnings Conference Call March 28, 2024 4:30 PM ET

Company Participants

Blake Chamblee - Investor Relations
Steve Croskrey - Chairman and Chief Executive Officer
Mike Hajost - Chief Financial Officer

Conference Call Participants

Jon Tanwanteng - CJS Securities
Thomas Boyes - TD Cowen
Laurence Alexander - Jefferies

Operator

Welcome to the Danimer Scientific 2023 Fourth Quarter Earnings Call. At this time all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. Instructions will be provided at that time for you to queue up for a question. [Operator Instructions]

I would now like to turn the presentation over to Mr. Blake Chamblee, the Company's representative. Please go ahead.

Blake Chamblee

Thank you, operator. Good afternoon, everyone, and thank you for joining us today for Danimer Scientific's 2023 fourth quarter earnings call.

Leading the call today are: Steve Croskrey, Chairman and Chief Executive Officer, and Mike Hajost, Chief Financial Officer. I'd like to note that there is a slide deck that accompanies today's discussion, which is available on the investor relations section of our website at danimerscientific.com.

As we begin, I'll call your attention to the company's Safe Harbor language, which is published in our SEC filings, and on slide two of the presentation I just referenced. On today's call, we may discuss forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995 as amended. Forward-looking statements include, among other things, statements regarding future results of operations including margins, profitability, capacity, production, customer programs, and market demand levels. Actual results could differ materially from what is expressed or implied in our forward-looking statements. The company assumes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

Today's presentation also includes references to non-GAAP financial measures within the meaning of SEC Regulation G. We believe these non-GAAP measures have analytical value, but note that they should be taken as supplementary measures of performance and not as alternatives to GAAP results. We have provided reconciliations for non-GAAP financial measures to the most comparable GAAP financial measures in our earnings release and our presentation.

Thank you, and it's now my pleasure to turn the call over to Steve Croskrey, Chairman and Chief Executive Officer, Danimer Scientific.

Steve Croskrey

Good afternoon, and thank you for joining us. The conclusion of the fourth quarter of 2023 marks the end of a challenging year as Danimer experienced delays in anticipated commercial launches. Despite these delays, we are greatly encouraged by our successes during the year and we believe we remain well ahead of the competition in both deep understanding of the bio-dividable plastics industry and the available production capacity to meet our current and future customers' needs.